Sanofi plans to invest around US$1.05 billion to build a new insulin production base in Beijing, which will mark the French ...

In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...

French pharma major Sanofi has added a new plant in Singapore to make vaccines and other medicines, as the company seeks to ...

Clinical trials for a revolutionary vaccine to treat acne will be conducted by the National Skin Centre in partnership with ...

Sanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in ...

Singapore's and Saudi Arabia's health officials have signed a memorandum of understanding to strengthen health sector ...

The home health hub market, valued at $0.80b in 2023, is expected to grow to $9.16b by 2032, with a compound annual growth ...

The 58,000 sq m plant – Sanofi’s second factory in Singapore – will produce vaccines and other biopharmaceutical products ...

Sanofi's $595m Singapore facility, Modulus, leverages advanced technology for rapid, flexible vaccine production, bolstering ...

Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...

A new experimental weight loss drug from Amgen — the first in a growing group of drugs aimed at once-a-month injections instead of once a week — helped patients lose up to 20% of their weight in one ...